Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-005449-12-IT
EUCTR2006-005449-12-IT
Active, Not Recruiting
N/A

EVALUATION OF THE EFFICACY OF THE TREATMENT WITH ACE-INHIBITORS ON THE RENAL DAMAGE IN PATIENTS AFFECTED BY GLYCOGEN STORAGE DISEASE TYPE 1 AND OF THE VITAMINE E ON NEUTROPENIA OF PATIENTS WITH GSD1b - GSD1: study of specific therapeutic intervention

Dipartimento di Pediatria0 sitesMay 23, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsQUARKEPHYNAL

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Dipartimento di Pediatria
Status
Active, Not Recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 23, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Dipartimento di Pediatria

Eligibility Criteria

Inclusion Criteria

  • •Inclusion criteria will be represented by the demonstration of the diagnosis of GSD 1a\-either by enzyme studies and/or mutation analysis\-and GSD1b\-either by enzyme studies and/or mutation analysis
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Exclusion criteria will be the inability to comply with the protocol and with the therapy.
  • •Pregnancy and breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Comparison of the effect of TDCS and RTMS in the treatment of migraine
IRCT20190404043159N4Esfahan University of Medical Sciences72
Completed
Phase 2
Treatment of schizophrenia with antipsychotic drugsSchizopherenia.Schizophrenia
IRCT138706051100N1Deputy of Research, Tehran University of Medical Sciences28
Completed
Phase 2
Ayurvedic Management Of Hepatitis BHealth Condition 1: K739- Chronic hepatitis, unspecified
CTRI/2018/05/014023Patanjali Ayurveda College50
Not Yet Recruiting
N/A
To evaluate the efficacy of Sarvakalpa-ghan-vati in management of non-alcoholic liver disorder.Health Condition 1: K77- Liver disorders in diseases classified elsewhere
CTRI/2020/07/026362Patanjali Research Institute
Active, Not Recruiting
Phase 1
Treating pulmonary fibrosis with co-trimoxazole
EUCTR2014-004058-32-GBorfolk and Norwich University Hospital NHS Foundation Trust330